Risk factors for recent HIV infection in Uganda.

CONTEXT Studies of factors associated with acquiring human immunodeficiency virus (HIV) are often based on prevalence data that might not reflect recent infections. OBJECTIVE To determine demographic, biological, and behavioral factors for recent HIV infection in Uganda. DESIGN AND SETTING Nationally representative household survey of cross-sectional design conducted in Uganda from August 2004 through January 2005; data were analyzed until November 2007. PARTICIPANTS There were 11,454 women and 9905 men aged 15 to 59 years who were eligible. Questionnaires were completed for 10,826 women (95%) and 8830 men (89%); of those interviewed, blood specimens were collected for 10,227 women (94%) and 8298 men (94%). MAIN OUTCOME MEASURE Specimens seropositive for HIV were tested with the BED IgG capture-based enzyme immunosorbent assay to identify recent seroconversions (median, 155 days) using normalized optical density of 0.8 and adjustments. RESULTS Of the 1023 HIV infections with BED results, 172 (17%) tested as recent. In multivariate analysis, risk factors associated with recent HIV infection included female sex (adjusted odds ratio [aOR], 2.4; 95% confidence interval [CI], 1.1-5.2); current marital status (widowed vs never married, aOR, 6.1; 95% CI, 2.8-13.3; divorced vs never married, aOR, 3.0; 95% CI, 1.5-6.1); geographic region (north central Uganda vs central Uganda/Kampala, aOR, 2.6; 95% CI, 1.7-4.1); number of sex partners in past year (> or = 2 compared with none; aOR, 2.9; 95% CI, 1.6-5.5); herpes simplex virus type 2 infection (aOR, 3.9; 95% CI, 2.6-5.8); report of a sexually transmitted disease in the past year (aOR, 1.7; 95% CI, 1.2-2.4); and being an uncircumcised man (aOR, 2.5; 95% CI, 1.1-5.3). Among married participants, recent HIV infection was associated with never using condoms with partners outside of marriage (aOR, 3.2; 95% CI, 1.7-6.1) compared with individuals having no outside partners. The risk of incident HIV infection for married individuals who used condoms with at least 1 outside partner was similar to that of those who did not have any partners outside of marriage (aOR, 1.0; 95% CI, 0.3-2.7). CONCLUSION A survey of individuals in Uganda who were tested with an HIV assay used to establish recent infection identified risk factors, which offers opportunities for prevention initiatives.

[1]  V. Mishra,et al.  HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey , 2008, AIDS.

[2]  Ekkehard Kopp,et al.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay , 2008, AIDS.

[3]  W. Hladik,et al.  The estimated burden of HIV/AIDS in Uganda, 2005–2010 , 2008, AIDS.

[4]  Yan Jiang,et al.  HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China , 2007, AIDS.

[5]  C. Morrison,et al.  Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe , 2007, AIDS.

[6]  R. Salamon,et al.  Do Tests Devised to Detect Recent HIV-1 Infection Provide Reliable Estimates of Incidence in Africa? , 2007, Journal of acquired immune deficiency syndromes.

[7]  S. S. Karim.  HIV incidence estimates are key to understanding the changing HIV epidemic in South Africa. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[8]  A. Puren,et al.  National HIV incidence measures--new insights into the South African epidemic. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[9]  T. Bärnighausen,et al.  Male circumcision to cut HIV risk in the general population , 2007, The Lancet.

[10]  A. Kamali,et al.  Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa , 2007, AIDS.

[11]  T. Wuhib,et al.  Temporal trends in the incidence of HIV infection in antenatal clinic attendees in Addis Ababa, Ethiopia, 1995–2003 , 2007, Journal of internal medicine.

[12]  B. Branson,et al.  Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. , 2006, AIDS research and human retroviruses.

[13]  K. D. de Cock,et al.  Unfinished business--expanding HIV testing in developing countries. , 2006, The New England journal of medicine.

[14]  S. Hugonnet,et al.  Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. , 2006, The Journal of infectious diseases.

[15]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[16]  A. Hyder,et al.  Exploring ethical considerations for the use of biological and physiological markers in population-based surveys in less developed countries , 2005, Globalization and health.

[17]  B. Branson,et al.  Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries , 2005, AIDS.

[18]  J. Mcdougal,et al.  Application of laboratory methods for estimation of HIV-1 incidence. , 2005, The Indian journal of medical research.

[19]  B. Roehr.  Abstinence programmes do not reduce HIV prevalence in Uganda , 2005, BMJ : British Medical Journal.

[20]  J. P. Ekwaru,et al.  Using HIV Voluntary Counseling and Testing Data for Monitoring the Uganda HIV Epidemic, 1992–2000 , 2004, Journal of acquired immune deficiency syndromes.

[21]  E. Asamoah-odei,et al.  HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences , 2004, The Lancet.

[22]  C. Pau,et al.  Performance Characteristics of the Immunoglobulin G-Capture BED-Enzyme Immunoassay, an Assay To Detect Recent Human Immunodeficiency Virus Type 1 Seroconversion , 2004, Journal of Clinical Microbiology.

[23]  J Ties Boerma,et al.  Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard , 2003, The Lancet.

[24]  J. Tappero,et al.  HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. , 2003, AIDS research and human retroviruses.

[25]  J. P. Ekwaru,et al.  Home-based model for HIV voluntary counselling and testing , 2003, The Lancet.

[26]  A. Kamali,et al.  Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study , 2002, The Lancet.

[27]  J. Changalucha,et al.  Comparison of HIV prevalences in community-based and antenatal clinic surveys in rural Mwanza, Tanzania , 2002, AIDS.

[28]  R. Byers,et al.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. , 2002, AIDS research and human retroviruses.

[29]  M. Wawer,et al.  HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda , 2001, AIDS.

[30]  R. Hayes,et al.  The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations , 2001, AIDS.

[31]  R. Hayes,et al.  Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials , 2000, The Lancet.

[32]  D. Katzenstein,et al.  Estimating HIV incidence from age‐specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe , 1998, AIDS.

[33]  G A Satten,et al.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.

[34]  T. Saidel,et al.  Simulation of HIV incidence dynamics in the Rakai population-based cohort, Uganda. , 1998, AIDS.

[35]  G. Tembo,et al.  Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda , 1997, AIDS.

[36]  M. Wawer,et al.  Trends in HIV‐1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population‐based cohort, Uganda , 1997, AIDS.

[37]  J. Rice,et al.  Validation of a method to estimate age-specific human immunodeficiency virus (HIV) incidence rates in developing countries using population-based seroprevalence data. , 1996, American journal of epidemiology.

[38]  J. Karon,et al.  High HIV‐1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaïre: estimating incidence from serial seroprevalence data , 1994, AIDS.

[39]  UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. , 2006, Releve epidemiologique hebdomadaire.

[40]  S. Weller,et al.  Condom effectiveness in reducing heterosexual HIV transmission. , 2002, The Cochrane database of systematic reviews.

[41]  HOMAS,et al.  VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .

[42]  C. Weinberg,et al.  Use and misuse of population attributable fractions. , 1998, American journal of public health.

[43]  J. Todd,et al.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: ra , 1995 .

[44]  John H. Seinfeld,et al.  Population-Level HIV Declines and Behavioral Risk Avoidance in Uganda , 2022 .